Modified Otago Exercise Program on Neurocognitive Level and Balance Parameters

September 16, 2026 updated by: Ayse Unal, Alanya Alaaddin Keykubat University

The Effect of Modified Otago Exercise Program on Neurocognitive Level and Balance Parameters in Community-Dwelling Older Adults: A Randomized Controlled Trial

This study examined the effect of an eight-week modified Otago Exercise Program on neurocognitive level and balance parameters in community-dwelling older adults.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Eighty-seven individuals aged 65 years and over were assigned to an intervention group (n=43) or a control group (n=44) through block randomization.

Study Type

Interventional

Enrollment (Actual)

87

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be 65 years of age or older,
  • Be able to walk at least ten meters unaided or with the support of a walking aid, - Not have a diagnosed neurological or orthopedic problem affecting walking and balance,
  • Not have visual or hearing impairments, and score 24 or higher on the Standardized Mini Mental State Test.

Exclusion Criteria:

  • Having undergone lower extremity surgery within the last six months and being illiterate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Otago Exercise

Otago exercise program + Daily routine
Other: Otago Exercise

Otago exercise + Daily routine
Active Comparator: Control

Daily routine
Other: Control

Only daily routine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive State Test
Time Frame: Enrollment and the end of 8 week-intervention

Cognitive State Test is a tool for the detailed screening of cognitive function. It is scored out of a total of thirty points. A high score corresponds to high cognitive performance.
Enrollment and the end of 8 week-intervention
Dynamic Balance Test
Time Frame: Enrollment and the end of 8 week-intervention

The Timed Up and Go Test was administered to assess dynamic balance. The time taken to complete the test was recorded; a shorter duration indicates good dynamic balance performance, whereas values exceeding 14 seconds are associated with an increased risk of falling.
Enrollment and the end of 8 week-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Warwick-Edinburgh Mental Well-being Scale
Time Frame: Enrollment and at the end of the 8th week

It consists of fourteen five-point Likert-type items and yields scores ranging from fourteen to seventy. A high score indicates a high level of mental well-being.
Enrollment and at the end of the 8th week
Single-Leg Stance Test
Time Frame: Enrollment and at the end of the 8th week

One leg is lifted without touching the supporting leg, and the individual is expected to maintain their balance for thirty seconds; the duration is recorded in seconds.
Enrollment and at the end of the 8th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Alanya Alaaddin Keykubat University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2024

Primary Completion (Actual)

May 10, 2026

Study Completion (Actual)

July 1, 2026

Study Registration Dates

First Submitted

September 6, 2026

First Submitted That Met QC Criteria

September 16, 2026

First Posted (Actual)

September 21, 2026

Study Record Updates

Last Update Posted (Actual)

September 21, 2026

Last Update Submitted That Met QC Criteria

September 16, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2024/05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe